J Herbmed Pharmacol. 2021;10(2): 209-217.
doi: 10.34172/jhp.2021.23

Scopus ID: 85103662178
  Abstract View: 2110
  PDF Download: 1000

Original Article

Effect of hydroalcoholic and aqueous extracts of Dracocephalum kotschyi on bleomycin induced pulmonary fibrosis

Ali Hosseini-Sharifabad 1 ORCID logo, Hassan Sadraei 1* ORCID logo, Mohammad Hashemnia 2 ORCID logo, Seyed Ebrahim Sajjadi 1 ORCID logo, Zahra Mirdamadi 1 ORCID logo

1 Isfahan Pharmaceutical Sciences Research Centre, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran
2 Department of Pathology, Faculty of Veterinary Medicine, Razi University, Kermanshah, I.R. Iran
*Corresponding Author: Email: sadraei@pharm.mui.ac.ir


Introduction: Dracocephalum kotschyi is an Iranian traditional medicine with anti-inflammatory and bronchodilatory properties. The objective of this research was to investigate the preventive effect of D. kotschyi extract in bleomycin induced fibrosis.

Methods: Fibrosis was induced by intratracheal administration of a single dose of bleomycin (5 mg/kg) in rat. One group received daily administration of normal saline. Other groups were treated daily with oral administration of either hydroalcoholic or aqueous extract of D. kotschyi (20, 40, & 80 mg/kg). Another group was treated with pirfenidone (100 mg/kg). After 4 weeks daily treatments, the animals were sacrificed and the whole lungs were dissected out for biochemical and histopathological examinations. The biochemical examination included assessment of hydroxyproline and malondialdehyde levels.

Results: The lung tissues in bleomycin treated groups showed severe tissue injuries. However, lung tissues in the groups that received hydroalcoholic or aqueous extracts of D. kotschyi showed mild to moderate tissue injuries. Intratracheal instillation of bleomycin significantly increased hydroxyproline and malondialdehyde biomarker levels compared with the sham group. In the positive control group treated with pirfenidone, there was a marked reduction in both hydroxyproline and malondialdehyde levels. Both hydroalcoholic and aqueous extracts of D. kotschyi significantly prevented the elevation of hydroxyproline and malondialdehyde levels at the above oral doses in comparison to the vehicle treated control group.

Conclusion: Prevention of hydroxyproline and malondialdehyde elevation levels in this experiment indicates that D. kotschyi extract might be a suitable remedy for the treatment of respiratory fibrosis induced by drugs such as bleomycin.

Dracocephalum kotschyi extracts displayed systemic anti-inflammatory and anti-fibrotic activities and reduced biochemical and histopathological indices of pulmonary inflammation and fibrosis. Therefore, it is might be useful for the prevention of idiopathic pulmonary fibrosis.
First Name
Last Name
Email Address
Security code

Abstract View: 2111

Your browser does not support the canvas element.

PDF Download: 1000

Your browser does not support the canvas element.

Submitted: 01 Apr 2020
Revision: 07 Jul 2020
Accepted: 07 Jul 2020
ePublished: 07 Jan 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)